2025. Formulation Development and Optimization of Taste-Masked Azithromycin Oral Suspension with Ion Exchange Resins, Including Bioanalytical Method Development and Validation, In Vivo Bioequivalence Study, and In-Silico PBPK Modeling for the Pediatric Population. Journal of Carcinogenesis. 24, 7s (Sep. 2025), 700–708. DOI:https://doi.org/10.64149/J.Carcinog.24.7s.700-708.